# EDGAR Filing Document

**Accession Number:** 0001769759
**File Stem:** 0001104659-25-084129
**Filing Date:** 2025-8
**Character Count:** 9685
**Document Hash:** 64470078ec1f85464b3352d98f18349a
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-25-084129.hdr.sgml**: 20250828

**ACCESSION NUMBER**: 0001104659-25-084129

**CONFORMED SUBMISSION TYPE**: DEFA14A

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20250828

**DATE AS OF CHANGE**: 20250827

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Monogram Technologies Inc.
- **CENTRAL INDEX KEY:** 0001769759
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 812349540
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** DEFA14A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41707
- **FILM NUMBER:** 251267127

**BUSINESS ADDRESS:**
- **STREET 1:** 3913 TODD LANE
- **STREET 2:** SUITE 307
- **CITY:** AUSTIN
- **STATE:** TX
- **ZIP:** 78744
- **BUSINESS PHONE:** 512-399-2656

**MAIL ADDRESS:**
- **STREET 1:** 3913 TODD LANE
- **STREET 2:** SUITE 307
- **CITY:** AUSTIN
- **STATE:** TX
- **ZIP:** 78744

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** MONOGRAM ORTHOPAEDICS INC
- **DATE OF NAME CHANGE:** 20190305

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**PURSUANT TO SECTION 13 OR 15(d)**

**OF THE SECURITIES EXCHANGE ACT OF 1934**

**Date of report (Date of earliest event reported): August 27, 2025**

**Monogram Technologies Inc.**

**(Exact name of registrant as specified in its charter)**

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-41707** | **81-3777260** |
| **(State or other jurisdiction**<br> **of incorporation)** | **(Commission**<br> **File Number)** | **(I.R.S. Employer**<br> **Identification Number)** |

---

**3913 Todd Lane, Austin, TX 78744**

**(Address of principal executive offices, including zip code)**

**Registrant's telephone number, including area code: (512) 399-2656**

**Not Applicable**

**(Former name or former address, if changed since last report)**

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

◻ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

⌧ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

◻ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

◻ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading**<br> **Symbol(s)** | **Name of each exchange**<br> **on which registered** |
| **Common Stock, par value $0.001 per share** | **MGRM** | **The Nasdaq Stock Market** |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ⌧

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻

**Item 1.01 Entry into a Material Definitive Agreement.**

*First Amendment to Merger Agreement*

As previously reported in the Current Report on Form 8-K dated July 14, 2025, Monogram Technologies Inc. ("Monogram" or the "Company"), a Delaware corporation, entered into an Agreement and Plan of Merger (the "Merger Agreement") with Zimmer Biomet Holdings, Inc. ("Parent"), a Delaware corporation, and Honey Badger Merger Sub, Inc. ("Merger Sub"), a Delaware corporation and wholly-owned subsidiary of Parent. Subject to the terms and conditions of the Merger Agreement, Merger Sub will be merged with and into the Company (the "Merger"), with the Company continuing as the surviving corporation and a wholly-owned subsidiary of Parent.

On August 27, 2025, in response to a verbal comment from the Securities and Exchange Commission, Parent and the Company entered into that certain First Amendment to Agreement and Plan of Merger (the "Amendment") to amend the definition of "Permitted Transfer" in the Form of CVR Agreement attached as Exhibit B to the Merger Agreement.

The foregoing description of the Amendment does not purport to be complete and is subject to, and is qualified in its entirety by reference to, the full text of the Amendment, which is attached as Exhibit 2.1 to this Current Report on Form 8-K.

**Item 9.01 Financial Statements and Exhibits.**

(d) The following exhibits are filed with this Current Report on Form 8-K.

---

| | |
|:---|:---|
| **Exhibit** | **Description** |
| [2.1](tm2524528d1_ex2-1.htm) | [First Amendment to Agreement and Plan of Merger, dated August 27, 2025, by and among Zimmer Biomet Holdings, Inc., and Monogram Technologies Inc.](tm2524528d1_ex2-1.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

 **SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | |
|:---|:---|
|  | **MONOGRAM TECHNOLOGIES INC.** |
| Dated: August 27, 2025 | /s/ Benjamin Sexson |
|  | Benjamin Sexson |
|  | Chief Executive Officer |

---

## Exhibit 2.1

**Exhibit 2.1**

**<u>FIRST AMENDMENT TO AGREEMENT AND PLAN OF MERGER</u>**

THIS FIRST AMENDMENT TO AGREEMENT AND PLAN OF MERGER (this "***Amendment***") by and between Zimmer Biomet Holdings, Inc., a Delaware corporation ("***Parent***") and Monogram Technologies Inc. ("***Company***", together with Parent, each a "***Party***" and collectively, the "***Parties***") is entered into as of August 27, 2025.

**BACKGROUND**

WHEREAS, the Company, Parent and Honey Badger Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent ("***Merger Sub***") previously entered into that certain Agreement and Plan of Merger dated July 11, 2025 (the "***Original Agreement***");

WHEREAS, pursuant to Section 8.1 of the Original Agreement, the Original Agreement may be amended at any time prior to the receipt of the Company Stockholder Approval by execution of an instrument in writing signed on behalf of each of Parent and the Company; and

WHEREAS, the Parties hereto desire to amend the definition of "Permitted Transfer" in the CVR Agreement attached as Exhibit B to the Original Agreement in accordance with this Amendment.

**AGREEMENT**

NOW, THEREFORE, in consideration of the representations, warranties, covenants and agreements contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereto, intending to be legally bound, hereby consent and agree as follows:

1. <u>Amendment</u>. Clause (g) in the definition of "Permitted Transfer" in the CVR Agreement
attached as Exhibit B to the Original Agreement is hereby deleted.

2. <u>Miscellaneous</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. *Full Force and Effect; References to Original Agreement*. Except as expressly modified hereby, all
of the terms and provisions of the Original Agreement shall remain in full force and effect, without modification or limitation. For purposes
of the Original Agreement, the term "Agreement" shall be deemed to mean the Original Agreement, as amended by this Amendment.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. *Counterparts*. This Amendment may be executed in counterparts, each of which shall be an original
for all purposes and all of which counterparts taken together shall constitute one and the same agreement. Signatures to this Amendment
executed and/or transmitted by electronic means shall be valid and effective to bind the Party so signing.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. *Governing Law*. This Amendment and the rights and obligations of the Parties shall be interpreted,
construed and enforced in accordance with the laws of the State of Delaware.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. *Definitions*. All capitalized terms used but not otherwise defined herein are used with the respective
definitions given to them in the Original Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e. *Entire Agreement*. The Original Agreement, as amended by this Amendment, contains the entire agreement
of the Parties with respect of the subject and supersedes all prior conversations, discussions and agreements relating to the subject
matter of this Amendment.

*[Signatures follow.]*

 

**IN WITNESS WHEREOF**, the undersigned parties have duly executed this Amendment as of the date first above written.

---

| | |
|:---|:---|
| **ZIMMER BIOMET HOLDINGS, INC.** | **ZIMMER BIOMET HOLDINGS, INC.** |
| By: | /s/ Chad F. Phipps |
| Name: Chad F. Phipps | Name: Chad F. Phipps |
| Title: Senior Vice President, General Counsel and Secretary | Title: Senior Vice President, General Counsel and Secretary |
| **MONOGRAM TECHNOLOGIES INC.** | **MONOGRAM TECHNOLOGIES INC.** |
| By: | /s/ Noel Knape |
| Name: Noel Knape | Name: Noel Knape |
| Title: Chief Financial Officer | Title: Chief Financial Officer |

---

[*Signature Page to First Amendment to Agreement and Plan of Merger*]